Home Wires

Equities

Listed stock commentary covering small-caps to big-caps, growth to income, domestic to global, and momentum to deep value.

Latest: Equities

Equities

Is the Commonwealth Bank's share price surge the ultimate bubble signal?

CBA has been a popular inclusion in many Australian investors’ portfolios. But has its surge been too good for too long?
CSL
GMG
+2
Reece Birtles
Martin Currie
Equities

Bumper cash generation set to help gold stocks catch up to booming bullion price

As well as share price re-rates among producers, expect more M&A like that being undertaken by Minerals 260 and Sipa.
BGL
+9
Barry FitzGerald
Independent Journalist
Equities

Conviction stock-picking drives biotech success: a biotech market review of 2024

Selective stock-picking and conviction drove HB Biotech’s strong 2024 performance. Read our insights on navigating today’s biotech market.
+7
Charlie Williams
HB Biotechnology
Outlook Series

2 ASX stocks giving you access to a misunderstood but highly profitable commodities theme

We are particularly focused on the growing demand for energy and critical minerals as key themes.
Emanuel Datt
Datt Capital
Outlook Series

The 10 most-tipped ASX income stocks for 2025

Here you will find your top-tipped ASX income stock picks from the 2025 Outlook Series Survey.
APA
BHP
+7
Sara Allen
Livewire Markets
Outlook Series

4 small and mid-caps to watch, and 1 to avoid after a 400% run

Spheria's Brittany Isakka shares the thought process her team uses when investing in and avoiding small and mid-caps.
HLS
MSB
PPS
+2
James Marlay
Livewire Markets
Equities

Where the Australian stock market is headed in 2025

There were massive winners and massive losers on the ASX in 2024. We bring you 2025 outlooks from three major brokers: Buy, hold or sell?
AMP
+17
Carl Capolingua
Livewire Markets
Outlook Series

The sectors and asset classes Livewire readers tip will outperform in 2025

And the stocks you and the experts tipped for exposure in the 2025 Outlook Series Survey.
360
BHP
BOE
+21
Sara Allen
Livewire Markets
Outlook Series

Caution! 11 stocks on the ‘avoid’ list for 2025

Avoiding big losses is a sure way to help compound your wealth. Nine professional investors share the stocks they're avoiding in 2025
IPH
+6
Buy Hold Sell
Livewire Markets
Outlook Series

This ASX name is guiding to 15% profit growth and has a founder who is buying

As part of the 2025 Outlook Series, Livewire interviewed 10 fund managers. Here, we share the full interview with Ellerston's James Barker.
DSE
QOR
Chris Conway
Livewire Markets
Outlook Series

Global growth and shorting opportunities abound

There's robust potential in US tech, pharma and Qantas, while red flags exist in a number of ASX companies that make them short candidates.
+7
Dr David Allen
Plato Investment Management
Outlook Series

The Magnificent Seven name that Sam Ruiz thinks is worth a miss

Plus, why he's fishing in life insurance for a portfolio idea in 2025.
Chris Conway
Livewire Markets
Equities

The rise and fall of Magellan and Platinum: Lessons for investors (podcast)

In Episode 34 of Stocks Neat, Portfolio Manager, Gareth Brown, and I take a deep dive into the challenges facing active fund management giants Magellan and Platinum,...
Steve Johnson
Forager
Outlook Series

The 10 most-tipped ASX growth stocks for 2025

Can your picks, including CSL, BHP and WTC, do it again in 2025? Here are the 10 top-tipped growth stocks for 2025.
360
BHP
+7
Sara Allen
Livewire Markets
Equities

Newmont – worth its weight in gold?

In this extract from our December 2024 Quarterly Commentary, we discuss the year that was and dig into Newmont Corporation.
Simon Mawhinney
Allan Gray
Outlook Series

Could this ASX-listed biotech stock become the next takeover battleground?

Plus, true bull markets never leave small and mid-caps out. Is this the year that they finally break out?
Chris Conway
Livewire Markets
Equities

This company is redefining electronic trading - and seeing phenomenal growth

In the crowded world of electronic trading platforms, Interactive Brokers (IBKR) stands out with its technology leadership, product breadth and industry-leading...
George Hadjia
Bristlemoon Capital
Equities

Chasing the sun

As emotions run high, anchoring on rational fundamentals is tougher, but probably more important than ever.
CAR
REA
+1
Martin Conlon
Schroders
Outlook Series

12 contrarian calls that may just surge in 2025

In this video, we ask our fundies to nominate some contrarian stock picks. Will any of them deliver the right kind of surprise? Find out.
+8
Buy Hold Sell
Livewire Markets
Equities

Is Boss Energy or Paladin Energy the better ASX uranium stock? This broker says buy both

The uranium trade was a rocky one in 2024 and appears to be starting 2025 on an equally uncertain basis. Bell Potter says: Stay the course.
AEE
+8
Carl Capolingua
Livewire Markets
Outlook Series

ZIP rallied 363% in 2024; Pendal's Rachel Folder says the growth is just getting started

As part of the 2025 Outlook Series, Livewire interviewed 10 fund managers. Here, we share the full interview with Pendal's Rachel Folder.
James Marlay
Livewire Markets
Equities

Could 2025 be the year that valuations matter again?

Valuations are rising, while the equity risk premium is shrinking. Here's how we're approaching markets this year.
AMC
ORI
+1
Daniel Moore
IML
Equities

5 ASX stocks to own as the market keeps rallying

In this wire we highlight five stocks we think are worth owning as the bull run continues into 2025.
CYC
+2
Michael Carmody
Centennial Asset Management
Equities

The anatomy of boom-bust cycles in a passive dominated market

Stock market booms and busts are rare. However, the dominance of passive investing has fuelled a dangerous cycle of market instability.
+2
Jason Teh
Vertium Asset Management
Equities

Your 2025 ASX highest dividend yield stocks playbook

The ASX hosts some of the best dividend stocks in the world. We investigate juiciest dividend yields on offer ahead of earnings season.
AMC
APA
+22
Carl Capolingua
Livewire Markets
1-25 of 7188